GNI Group (TSE:2160) EBIT: 円-5,074 Mil (TTM As of Mar. 2026)


TSE:2160 GNI Group Ltd TSE:2160
83 GF Score
Price 円2,517.00
GF Value 円2,777.99
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is GNI Group EBIT?

GNI Group TSE:2160 -2.52% 83 EBIT is 円-5,074 Mil as of Mar. 2026. GuruFocus rates TSE:2160 with a GF Score™ of 83/100 and a GF Value™ of 円2,777.99 (Fairly Valued). The stock has 5 warning signs investors should review.

GNI Group's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円-2,599 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-5,074 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. GNI Group's annualized ROC % for the quarter that ended in Mar. 2026 was -21.15%. GNI Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -83.05%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. GNI Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -4.23%.


GNI Group  (TSE:2160) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

GNI Group's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-10996 * ( 1 - 0% )/( (51099 + 52863)/ 2 )
=-10996/51981
=-21.15 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

GNI Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-10396/( ( (7501 + max(5326, 0)) + (7584 + max(4624, 0)) )/ 2 )
=-10396/( ( 12827 + 12208 )/ 2 )
=-10396/12517.5
=-83.05 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8056 + 3752 + 927) - (4693 + 0 + 2716)
=5326

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6219 + 4119 + 1039) - (3759 + 0 + 2994)
=4624

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

GNI Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-5074.345/120019.571
=-4.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GNI Group EBIT Related Terms


GNI Group EBIT Historical Data

* Premium members only.

The historical data trend for GNI Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GNI Group EBIT Chart

GNI Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,754.91 1,637.77 13,863.43 2,118.00 -2,884.00

GNI Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -408.66 -230.46 753.12 -2,998.00 -2,599.00

TSE:2160 vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, GNI Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GNI Group EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where GNI Group's EV-to-EBIT falls into.


TSE:2160
83GF Score
GNI Group Ltd TSE:2160
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GNI Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-5,074 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円-5,074 Mil mean?
GNI Group (TSE:2160) has a EBIT of 円-5,074 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on GNI Group.
Is GNI Group's EBIT too high?
GNI Group's current EBIT is 円-5,074 Mil. Overall, GNI Group has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GNI Group's EBIT compare to VRTX and REGN?
GNI Group's EBIT of 円-5,074 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on GNI Group. GNI Group's current EBIT is 円-5,074 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
Based on GuruFocus' analysis, GNI Group (TSE:2160) is currently considered Fairly Valued. The stock's GF Value™ is 円2,777.99, compared to a current price of 円2,517.00 — trading 9.4% below its estimated fair value. The current EBIT is 円-5,074 Mil. GNI Group's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For GNI Group (TSE:2160), the current EBIT is 円-5,074 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GNI Group (TSE:2160) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of 円2,517.00 is trading 9.4% below its estimated GF Value™ of 円2,777.99. GuruFocus considers GNI Group to be Fairly Valued.

Key valuation signals for TSE:2160:

  • EBIT: 円-5,074 Mil
  • GF Value™: 円2,777.99 vs. price of 円2,517.00 (9.4% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the TSE:2160 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GNI Group Business Description

Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
83GF Score

Get the complete analysis for TSE:2160

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,517.00
Price
円2,777.99
GF Value